Anticoagulation Management in Arrhythmia Patients

Penn electrophysiologist David J. Callans, MD, offers insights on what is perhaps the most difficult medical issue confronting clinicians who treat the arrhythmias: the use of anticoagulants. Dr. Callans discusses the nuances of anticoagulation across the spectrum of the arrhythmia population, discussing the peri-procedural parameters for starting and stopping these agents, bleeding and thromboembolic risks, and comparisons of warfarin and the new generation of blood thinning drugs.


Related Links


January 7, 2015

Created by

Penn Physician VideoLink